HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trial of octacosanol in amyotrophic lateral sclerosis.

Abstract
Octacosanol was tried in amyotrophic lateral sclerosis in a double-blind, placebo-controlled, crossover design. Neurologic and pulmonary function evaluations showed no benefit.
AuthorsF H Norris, E H Denys, R J Fallat
JournalNeurology (Neurology) Vol. 36 Issue 9 Pg. 1263-4 (Sep 1986) ISSN: 0028-3878 [Print] United States
PMID3528918 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Alcohols
  • Placebos
  • 1-octacosanol
Topics
  • Aged
  • Amyotrophic Lateral Sclerosis (drug therapy)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Fatty Alcohols (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Placebos

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: